Clinical Trial Update: Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, multicenter trial evaluating intravenous bisphosphonate for stress fracture treatment has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Fracture of the Ankle
• Stress Fracture of the Foot

Drugs mentioned

• intravenous bisphosphonate

Snippet

Sponsor: Oslo University Hospital | Conditions: Stress Fracture Foot, Stress Fracture Ankle | Phase 4 | Status: TERMINATED